Furthermore, they are convinced that PKM2 is a packaging protein for GC cell exosomes, with mJPYZ reducing the delivery of tumor cell exosomal PKM2 to macrophages and alleviating exosomal PKM2-induced M2-TAM differentiation in the tumor microenvironment, consequently inhibiting GC progression. The gene discussed is PKM; the disease is gastric cancer.